Oncolytics Biotech® Successfully Raises US$15 Million to Advance Breast and Pancreatic Cancer Clinical Programs

/PRNewswire/ -- Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (NASDAQ: ONCY) (TSX: ONC) today announced the closing (the "Closing") of the...

Related Keywords

Quebec ,Canada ,United States ,Canadian ,Timothy Mccarthy ,Jon Patton ,Leede Jones Gable Inc ,Oncolytics Biotech Inc ,Company Contact ,Securities Exchange ,National Instrument ,Oncolytics Biotech ,Jones Gable ,Each Equity Unit ,Common Share ,Each Warrant ,Underwriting Agreement ,Equity Units ,Common Shares ,Each Compensation Warrant ,Warrant Share ,Short Form Prospectus Distributions ,United States Securities Act ,Securities Exchange Act ,Compensation Warrants ,Over Allotment Option ,